drugset / Trial / NCT03505788

Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR)

NCT03505788

Phase 4 Completed 519 enrolled Ziekenhuis Oost-Limburg
RandomizedParallel-groupTriple-blindTreatment

Summary

This clinical research study is being conducted in multiple hospitals in Belgium and approximately 519 patients with acute decompensated heart failure are expected to participate. Large-scale research shows that 90% of the physicians treat volume overload with high doses of loop diuretics. However, there is not a lot of scientific data available regarding the optimal doses of these diuretic medications. In addition, it is observed that a lot of people, treated with these drugs, are being readmitted to the hospital due to a new episode of heart failure. The hypothesis of this study is that the volume overload could be better treated when patients receive a combination of different types of diuretics. Additionally, the total dose of the administrated diuretics might be lower this way.

Timeline

Start
2018-11-11
Primary completion
2022-01-20
Completion
2022-05-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 500 mg Intravenous

Indications